EirGenix provides not just technology services but integral solutions that you can rely on.
Eirgenix develops high quality biologic products, advancing an extensive pipeline of candidates to improve the lives of patients.
2018 Biologics Manufacturing Korea
Ongoing Cancer Therapeutic Drug EG12014 Is Approved For Phase III Clinical Trial
EirGenix is award Top 145 of The Technology Fast 500 Companies in Asia Pacific (APAC)
EIRGENIX RECEIVED “Asia’s Best CMO”
Our facility is located in Taiwan, and offers the service to clients around the world.
